Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisa Nuti
Observed names:
E Nuti,
E. Nuti,
NUTI ELISA,
NUTI, ELISA,
Nuti E,
Nuti, E.,
Nuti, Elisa
show all 7
Institution:
University of Pisa
Observed institutions:
University of Pisa,
University of Macau,
Instituto Superior Técnico,
Centro de Química Estrutural,
University of Florence,
Temple University
show all 6
ORCID:
0000-0003-2669-5376
Observed ORCID:
0000-0003-2669-5376
OpenAlex ID:
A5063190899
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
2021
·
Matteo Calligaris
, Doretta Cuffaro
, et al.
·
Molecules
·
116
PDF
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies
2013
·
Murat Bozdag
, Marta Ferraroni
, et al.
·
Bioorganic & Medicinal Chemistry
·
110
Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
2007
·
Elisa Nuti
, Tiziano Tuccinardi
·
Current Pharmaceutical Design
·
109
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2)
2004
·
Armando Rossello
, Elisa Nuti
, et al.
·
Bioorganic & Medicinal Chemistry
·
86
Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II
2016
·
Takehiko Takayanagi
, Steven J. Forrester
, et al.
·
Hypertension
·
83
PDF
N - O -Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity
2015
·
Elisa Nuti
, Anna Rita Cantelmo
, et al.
·
Journal of Medicinal Chemistry
·
75
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides
2006
·
Tiziano Tuccinardi
, Adriano Martinelli
, et al.
·
Bioorganic & Medicinal Chemistry
·
72
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies
2018
·
Elisa Nuti
, Doretta Cuffaro
, et al.
·
Journal of Medicinal Chemistry
·
68
Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity, and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups
2014
·
Murat Bozdag
, Marta Ferraroni
, et al.
·
Journal of Medicinal Chemistry
·
65
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis
2009
·
Elisa Nuti
, Francesca Casalini
, et al.
·
Journal of Medicinal Chemistry
·
59
Crystallization of bi-functional ligand protein complexes
2013
·
Claudia Antoni
, Laura Vera
, et al.
·
Journal of Structural Biology
·
56
Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma
2010
·
P. Gabelloni
, E. Da Pozzo
, et al.
·
Neuroscience
·
56
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors
2009
·
Elisa Nuti
, Laura Panelli
, et al.
·
Journal of Medicinal Chemistry
·
55
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models
2016
·
Caterina Camodeca
, Elisa Nuti
, et al.
·
European Journal of Medicinal Chemistry
·
52
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
2015
·
Maria Raffaella Zocchi
, Caterina Camodeca
, et al.
·
OncoImmunology
·
52
PDF
Targeting ADAM17 Sheddase Activity in Cancer
2016
·
Armando Rossello
, Elisa Nuti
, et al.
·
Current Drug Targets
·
51
Sugar‐Based Arylsulfonamide Carboxylates as Selective and Water‐Soluble Matrix Metalloproteinase‐12 Inhibitors
2016
·
Elisa Nuti
, Doretta Cuffaro
, et al.
·
ChemMedChem
·
51
An overview of carbohydrate-based carbonic anhydrase inhibitors
2020
·
Doretta Cuffaro
, Elisa Nuti
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
49
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
2017
·
Francesca Tosetti
, Roberta Venè
, et al.
·
OncoImmunology
·
49
PDF
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate−Benzenesulfonamide Conjugates
2008
·
Sérgio M. Marques
, Elisa Nuti
, et al.
·
Journal of Medicinal Chemistry
·
49
Discovery of 1,1′-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors
2015
·
Giuseppe La Regina
, Antonio Coluccia
, et al.
·
Journal of Medicinal Chemistry
·
46
The metalloproteinase ADAM10 requires its activity to sustain surface expression
2020
·
Anke Seifert
, Stefan Düsterhöft
, et al.
·
Cellular and Molecular Life Sciences
·
45
PDF
Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity
2017
·
Barbara Oliviero
, Stefania Mantovani
, et al.
·
Journal of Hepatology
·
43
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study
2007
·
Tiziano Tuccinardi
, Elisa Nuti
, et al.
·
Journal of Chemical Information and Modeling
·
43
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates
2007
·
Elisa Nuti
, Elisabetta Orlandini
, et al.
·
Bioorganic & Medicinal Chemistry
·
43
Show more works
View as search
Works count:
213
Citation count:
2,747
H-index:
33
I10-index:
69
Year
Topic
Type
